Cost–Utility of First-Line Actinic Keratosis Treatments in Finland

INTRODUCTION: Cost–utility assessment of first-line actinic keratosis (AK) treatments for max 25 cm(2) AK field. METHODS: A probabilistic, 2-year decision tree model was used to assess costs, quality-adjusted life-years (QALY), incremental cost-effectiveness ratio (ICER), cost-effectiveness efficien...

Descripción completa

Detalles Bibliográficos
Autores principales: Soini, Erkki J., Hallinen, Taru, Sokka, Anna-Leena, Saarinen, Kari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449383/
https://www.ncbi.nlm.nih.gov/pubmed/26006101
http://dx.doi.org/10.1007/s12325-015-0211-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449383/
https://www.ncbi.nlm.nih.gov/pubmed/26006101
http://dx.doi.org/10.1007/s12325-015-0211-7

Ejemplares similares